[ARWR] QoQ Quarter Result on 31-Dec-2022 [#Q1]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
06-Feb-2023
Financial Year
2023
Quarter
31-Dec-2022 [#Q1]
Profit Trend
QoQ- 51.35%
YoY- 33.50%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 16,097 15,825 146,267 62,546 31,575 32,412 151,805 -77.56%
PBT -108,990 -103,383 47,676 -41,794 -82,157 -72,046 44,366 -
Tax 2,025 742 -999 17 3,785 -863 -2,813 -
NP -109,679 -102,946 48,675 -41,811 -85,942 -71,183 44,366 -
Tax Rate - - 2.10% - - - 6.34% -
Total Cost 125,776 118,771 97,592 104,357 117,517 103,595 107,439 11.06%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -681.36 -650.53 33.28 -66.85 -272.18 -219.62 29.23 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -1.02 -0.96 0.46 -0.39 -0.81 -0.67 0.42 -
EPS Diluted -1.02 -0.96 0.45 -0.39 -0.81 -0.67 0.41 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.